Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-137938
Filing Date
2024-12-18
Accepted
2024-12-18 16:37:28
Documents
1
Period of Report
2024-12-16

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 6000
  Complete submission text file 0000950170-24-137938.txt   7695
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Issuer) CIK: 0001213037 (see all company filings)

EIN.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 55 CAMBRIDGE PARKWAY 8TH FLOOR CAMBRIDGE MA 02142
Business Address
Levine James E. (Reporting) CIK: 0001463151 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35558 | Film No.: 241559801